The biggest names in AI just agreed on something, which almost never happens. Anthropic’s Dario Amodei, OpenAI’s Sam Altman, and Microsoft’s Mustafa Suleyman have signed an open letter pressing the US Congress to close what they call a dangerous biosecurity gap, according to The Verge AI. The fear behind it is blunt: AI tools could make it easier for bad actors to design biological weapons capable of triggering a global pandemic.
This is significant because these companies fight each other over talent, customers, and market share almost daily. Seeing them line up behind the same policy ask tells you they take the threat seriously.
What they’re asking for
The letter, as detailed in The Verge AI, targets one specific weak point: the companies that sell synthetic DNA and RNA. That’s genetic material you can order online and assemble in a lab. The signatories want Congress to require those sellers to screen every purchase for sequences that could be used to build dangerous pathogens.
The core demands break down like this:
- Make screening of synthetic DNA and RNA orders mandatory, not voluntary.
- Keep detailed records on all orders so any threat that slips past the first check can be tracked.
- Act fast, because the underlying technology is changing quickly.
Who signed
The list goes well beyond the three CEOs. Meta’s AI chief Alexandr Wang signed, along with Google DeepMind’s Demis Hassabis, who won the 2024 Nobel Prize in Chemistry for his work on AI-based protein prediction. Prominent scientists, national security experts, and policy people joined too.
Notably, executives from biotech firms Twist Bioscience and Ansa Biotechnologies signed as well. Both are major sellers of synthetic genetic material, which means companies are volunteering to be regulated. That’s rare, and it adds weight to the ask. The Verge AI reports the effort was organized by two think tanks, the Foundation for American Innovation and the Institute for Progress.
Why this matters now
Scientists have warned for years that synthetic biology could let someone engineer dangerous organisms or even resurrect long-dead pathogens. What kept that risk contained was access. The work required skilled scientists, sophisticated labs, expensive equipment, and deep expertise.
That barrier is what’s eroding. Two trends are colliding:
- Biological tools are getting cheaper and more accessible.
- AI models are getting more capable at designing complex genetic sequences.
Put those together and tasks that once needed a specialist could become far easier for someone without that training. The letter warns AI could help produce other threats too, including chemical weapons.
What stands out here is the gap between current practice and policy. Many of the largest DNA and RNA providers already screen orders. But it’s voluntary. There’s no law forcing it, no requirement for the smaller players, and no mandated record-keeping. The signatories want to turn a patchwork of good intentions into an enforced standard.
The bigger picture
This fits a pattern we’ve watched build over the past two years. AI leaders keep flagging catastrophic risks while racing to ship more powerful models. Critics will note the tension there. But asking to regulate the supply chain for physical genetic material is more concrete than most safety pledges. It points at a specific chokepoint instead of vague promises.
“This is a rare moment of agreement across stakeholders that are often at odds,” the letter says. “We hope policymakers will meet it with decisive action.”
What to expect next
The pressure now sits with Congress. Mandatory screening would land first on synthetic biology suppliers, not on the AI labs themselves, so watch how biotech firms and lawmakers respond to the cost and compliance burden. If rules move forward, expect screening standards, order-tracking requirements, and likely some federal oversight body to enforce them.
For anyone building or deploying AI in life sciences, this is an early signal. Biosecurity guardrails are coming, and the people who run the largest models are the ones asking for them. You can find the full details at the original source.